GI/Liver/Nutrition and Critical Care PRN Focus Session — Cry Me a Liver: Updates in the Management of Hepatorenal Syndrome

Hepatorenal syndrome (HRS) is a serious complication of advanced liver disease, characterized by kidney dysfunction related to circulatory changes caused by cirrhosis and associated with significant mortality. Although HRS is considered a diagnosis of exclusion, the diagnostic criteria for HRS have recently been revised to reflect differences in AKI in patients with cirrhosis. Additionally, although treatment options are limited for the treatment of HRS, terlipressin has been recently approved for use in the United States for this indication. The purpose of this session is to provide updates in the diagnostic criteria for HRS and management of HRS including vasoactive therapy and use of albumin. 

Moderator: Stephanie Bass, Pharm.D., FCCP, BCCCP, BCPS Medical ICU Clinical Pharmacist Cleveland Clinic Cleveland, Ohio   View Biography

Root of All Renal: An Update on the Diagnostic Criteria for HRS 2:15 PM to 2:45 PM Speaker: Jason Yerke, Pharm.D., BCCCP No speaker description available.   View Biography

Under Pressure: An Update on Vasoconstrictor Therapy for HRS 2:45 PM to 3:15 PM Speaker: Payal Kakadiya, Pharm.D., BCPS Clinical Pharmacist Practitioner, GI/IBD  University of North Carolina Health Chapel Hill, NC   View Biography

Volume for improvement: An Update on the Use of Albumin in the Management of HRS 3:15 PM to 3:45 PM Speaker: Emily J. Owen, Pharm.D., Masters in Research, BCCCP, BCPS